跳至主要内容
临床试验/NCT00776750
NCT00776750已完成4 期

Influenza Vaccination in Hemodialysis Patients and Renal Transplant Recipients

Universitaire Ziekenhuizen KU Leuven2 个研究点 分布在 1 个国家目标入组 407 人开始时间: 2003年9月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
407
试验地点
2
主要终点
Seroprotection rate, defined as the percentage of patients with an HI antibody titer ≥ 40,

研究概览

简要总结

Disturbances of acquired immunity are considered to be responsible, at least partly, for the high infection rate and inadequate response to vaccinations observed in hemodialysis (HD) patients and renal transplant recipient (RTR). The present prospective trial aims at (a) evaluating the immunogenicity of a standard influenza vaccine in HD and RTR patients and (b) at identifying determinants of the immune response.

研究设计

研究类型
Interventional
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • maintenance hemodialysis patients or
  • renal transplant recipients (beyond month 3 after transplantation)

排除标准

  • patients with known allergy to chicken proteins

结局指标

主要结局

Seroprotection rate, defined as the percentage of patients with an HI antibody titer ≥ 40,

次要结局

  • Seroresponse rate, defined as the percentage of patients with a fourfold rise in HI titer after vaccination; impact of booster vaccination on the immune response, and safety of influenza vaccination.

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验